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Background: Essential genes are critical for the development of all organisms and are associated with many
human diseases. These genes have been a difficult category to study prior to the availability of balanced lethal
strains. Despite the power of targeted mutagenesis, there are limitations in identifying mutations in essential genes.
In this paper, we describe the identification of coding regions for essential genes mutated using forward genetic
screens in Caenorhabditis elegans. The lethal mutations described here were isolated and maintained by a wild-type
allele on a rescuing duplication.
Results: We applied whole genome sequencing to identify the causative molecular lesion resulting in lethality in
existing C. elegans mutant strains. These strains are balanced and can be easily maintained for subsequent
characterization. Our method can be effectively used to analyze mutations in a large number of essential genes.
We describe here the identification of 64 essential genes in a region of chromosome I covered by the duplication
sDp2. Of these, 42 are nonsense mutations, six are splice signal mutations, one deletion, and 15 are non-synonymous
mutations. Many of the essential genes in this region function in cell cycle, transcriptional regulation, and RNA processing.
Conclusions: The essential genes identified here are represented by mutant strains, many of which have more than
one mutant allele. The genetic resource can be utilized to further our understanding of essential gene function and will
be applicable to the study of C. elegans development, conserved cellular function, and ultimately lead to improved
human health.
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The proper development and viability of an organism is
dependent on a group of genes called essential genes. In
humans, gene essentiality has been long associated with
many diseases such as miscarriages [1,2], heritable dis-
eases, and cancer [3]. Recent studies have shown that
over-expression of some essential genes promotes cell
proliferation in cancer [4]. Due to its importance for sur-
vival, essential genes have been targets for new therapeu-
tics or antimicrobials [5]. To effectively study essential* Correspondence: jeff.sc.chu@gmail.com
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unless otherwise stated.genes, generating lethal alleles in model systems is
required. In the nematode Caenorhabditis elegans, the
essential gene set is the largest set of genes and is esti-
mated to contain 25% of all the genes [6-9]. Using RNAi,
about 3500 genes have been annotated as essential (data
collected from WormBase [10,11]). Inparanoid, a se-
quence based orthology inference tool, detects about
40% of the C. elegans genes are orthologous to the hu-
man genes. But approximately 60% of the essential genes
show clear human orthologs, showing high conservation
of essential genes, which makes C. elegans an excellent
platform for examination of essential gene functions that
are relevant to human health. Many important genes,
such as let-60/Ras [12] and let-740/dcr-1 [13,14], were. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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genetic resource for studying these genes is severely lack-
ing. Even with the concerted community effort such as the
C. elegans Deletion Mutant Consortium [15], mutations in
many essential genes are still lacking in the knock-out col-
lection. The consortium have generated close to 6000
knock-out strains since 1998, but only 1436 essential
genes are in the current collection [16,17]. In addition to
the considerable time and effort required to generate a
single knock-out allele, an outstanding disadvantage of the
targeted deletion approach is that extra effort is needed to
balance the lethal mutation [18]. Recently, the Consortium
has adopted a procedure of random mutagenesis followed
by whole genome sequencing (WGS) to generate and
identify a large number of mutations [15]. Although this
project can generate more mutations in shorter time, their
method does not capture mutations that exhibit lethal
phenotypes, and thus, essential genes are selected against.
This outcome indicates thousands of essential genes do
not have knockout alleles.
To complement the effort of the C. elegans community,
we took advantage of the balancer system, which was
developed 30 years ago for capturing and maintaining le-
thal mutations, with the next-generation DNA sequencing
technologies. Almost 70% of the C. elegans genome have
been successfully balanced by large genomic rearrange-
ments [18]. By mutagenizing a pre-balanced strain removes
the need to perform additional genetic crosses to balance a
lethal mutation. The balancer system, designed specifically
to capture and maintain lethal mutations, is the system of
choice for generating mutations in essential genes. Such
screens have been carried out for regions in chromosome I
[19,20], II [21], III [22], IV [23-26], V [27], and X [28,29].
In our laboratories, we have generated over 1350 lethal
mutations that fall into 486 complementation groups.
The next hurdle in the analysis of essential genes is the
molecular identification of the genomic lesion, which to
date has involved an enormous effort. Traditional methods
of gene cloning that rely upon candidate identification of
mapped mutations can take months or years. This gene-
by-gene approach was only able to characterize 30 essen-
tial genes from our library to date. This problem has been
difficult to solve until the recent advances in sequencing
technology. To address the problem of coding region
identification, we have recently developed a fast and scal-
able pipeline that takes advantage of whole genome se-
quencing and bioinformatics analysis to identify the causal
mutation responsible for the lethal phenotype [30]. Recent
studies, including our initial analysis of let-504 [30], have
shown that whole genome sequencing is an efficient and
cost-effective approach to identifying the encoded gene
product especially when there are additional alleles that
can be sequenced to provide confirmation [30-34]. In
this paper, we describe our approach of combining anestablished mutagenesis technique with the latest sequen-
cing technology in order to close the gap in the essential
gene knock-out collection.
Results and discussion
Chromosome I left has a high percentage of essential genes
The leftmost 7.3 Mbp of chromosome I has the highest
percentage of mapped essential genes and closest to satur-
ation with 237 essential genes isolated and mapped [19].
The mutant strains were derived by mutagenizing KR235
[dpy-5 (e61), +, unc-13 (e450)/dpy-5(e61), unc-15(e73), +;
sDp2] with a low dose of EMS and isolating let-x dpy-5
unc-13 homozygotes rescued with a third wild-type allele
of dpy-5 and let-x balanced by free duplication sDp2 [35]
(see schematic in Additional file 1). In order to position
the genes, mutations were mapped into 60 zones using a
combination of three-factor mapping and complementa-
tion to a series of duplications and deficiencies [19].
Within zones, lethal mutants were inter-complementation
tested. The earliest developmental arrest stages were de-
termined for each complementation group [19]. The can-
didate lesions are present in two copies and rescued by a
third wild-type allele on sDp2. Thus, our high throughput
identification method focused on finding heterozygous
mutations that exhibit an allelic ratio between the range of
40% to 90% [30]. In order to assess the accuracy of our re-
cently developed high throughput method [30], we se-
lected 81 genes from this set with the criteria that they
formed a complementation group having more than one
allele (Additional file 2). The extra alleles provide an added
resource for validation. We sequenced 10 indexed gen-
omic DNA samples per Illumina HiSeq lane and obtained
a total of 385 Gbp of sequence. The sequencing reads
were aligned using BWA [36] to the WS200 C. elegans ref-
erence sequence. We achieved 30X coverage on average
across the whole genome and an average of 35X coverage
in coding elements. In the case of two strains, only 6X
coverage was obtained: let-369(h125) and let-594(h407).
Genomes from these two strains were removed from sub-
sequent analysis.
The mutational landscape provided a quality check
Our first analytical step, as a quality check, was to con-
firm the presence of the dpy-5 (e61) and unc-13 (e450)
mutations in each genome. For unc-13, the expected
variant ratio should be 100% because the duplication
does not extend far enough to provide an additional
wild-type allele. For dpy-5 however, there is a wild-type
allele on sDp2, and thus we would expect to see a 66%
variant ratio. We found the expected ratios in 76 of the
79 genomes. Three genomes deviated from the norm:
let-516(h144) is missing both e450 and e61 (all the reads
supported the reference sequence); let-388(h88) is miss-
ing e61; let-393(h225) has e61, but with a 33% ratio
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strains for the presence of the duplication sDp2. When
the duplication is present, the read depth is 33% greater
in the first 7Mbp of chromosome I than for rest of the
chromosome. Our analysis showed that none of these
three genomes showed any depth difference (Additional
file 3). It is likely these strains do not carry sDp2. Al-
though sDp2 does not crossover with the normal homo-
logs at a readily detectable frequency, rare exchange
events can occur resulting in subsequent loss of the du-
plicated fragment [37]. These three strains were not ana-
lyzed further.
Coding sequence correlated with high confidence
We analyzed the parental strain KR235 and identified
571 SNVs and 167 small indels that show >40% read
support on Chromosome I when compared to the C. ele-
gans WS200 reference using VarScan (see Methods).
These mutations represent the background mutations in
which the lethal mutations were maintained. For the
remaining 76 genomes, we filtered out the background
mutations and found on average 44 SNVs that show >40%
allelic ratio in the sDp2 region. Most of the SNVs are
G > A or C > T changes as expected and previously
observed after EMS treatment [30,38]. We also found
an average of 7 small indels of 1–2 bps. We categorized
each mutation as either nonsense, missense, synonym-
ous, splice signal disruption, frame shifting indel, frame
preserving indel, or noncoding mutation. Noncoding
mutations were defined as any mutation located outside
of coding regions. A full list of SNVs and indels, for each
strain, is available on our server at http://lethal.mbb.sfu.
ca/jschu/essential_genes.
We identified candidate mutations for the 76 genomes
using our bioinformatics pipeline that we developed pre-
viously [30] (see also Methods) and validated a subset of
our candidates by sequencing a second allele or by com-
plementation testing (Table 1). Nine of our candidate le-
sions were in genes that had been previously identified
and published. In a few cases, candidates expected to be
in separate genes were located in the same coding re-
gion. These observations were confirmed by further gen-
etic complementation tests (Additional file 4). Previously
identified let-631 and let-103 were found to be allelic to
let-363. As a result, let-363 gains three new sDp2-
balanced alleles (h216, h451, h502) in addition to the
nine existing ones. let-519 and let-104 are allelic to let-
526 and thus let-526 gains four new alleles: h799, h373,
h405 and h526. let-630 fails to complement let-596 and
now has five alleles: h355, h702, h432, h782, and h258.
Thirty-five candidates were tested by sequencing a sec-
ond allele using previously published complementation
data [19]. Of these, we confirmed 29 identities. All in
all, we tested 48 candidates and confirmed 42 (87.5%).For the remaining 28 genomes, we have high confidence
in the identity of 22 genes based on their map position.
Thus, including previously described let-504, we now
have coding region assignments for 64 let- genes in the
sDp2 region. Because the genes in this study all have
multiple alleles, thus by inference, we have confidently
identified the coding regions affected in a total of 259
mutant strains (Additional file 2).
Seven of these genes have been molecularly identified
and phenotypically described. let-603, an aurora kinase
[46], and let-605, the cyclin E, had severe gonadal defects
[56]. let-355, a DEAD box helicase, and let-384, an inte-
grator subunit, failed to develop gametes [56]. let-370, let-
599, and let-604 produced malformed embryos that were
not laid or hatched [56]. let-370 encodes a hexaprenyl
pyrophosphate synthetase that is associated with Parkin-
son’s disease [51]. let-599 encodes the N-acetyl transferase
nath-10. let-604 encodes mdt-18, a mediator subunit. A
comprehensive summary of the let- encoded products is
given in Table 1.
Novel knock-out alleles provide new genetic resources
We have generated new alleles for 13 genes that currently
have no knock-out alleles available: let-595 (imb-1), let-
362 (Y71G12B.8), rnp-6 (let-147), aars-2 (let-366), let-598
(F27C1.6), let-355 (T05E8.3), let-384 (C06A5.1), fars-1
(let-396), let-611 (C48E7.2), mdt-18 (let-604), acdh-5 (let-
383), rpb-5 (let-397), and let-630 (Y110A7A.19). Eight of
these genes are predicted to have roles in essential basic
functions such as transcription or translation. This is not
surprising, because we expect genes that function in basic
cellular processes to be essential and are best captured
using balancer systems. Besides these novel alleles, we
have provided additional loss of function alleles for many
characterized genes (Table 1). Additional alleles affect-
ing different parts of the gene may disrupt different
domains providing an allelic series correlating with dif-
ferent phenotypes.
Genetic strains carrying heritable mutational changes
provide a lasting resource that can be used in a variety
of experimental conditions and compared to information
gained from RNAi knock-down experiments. We cross-
checked our high confidence list with the RNAi data an-
notated in WormBase to see if the lethal phenotype was
observed in at least two RNAi experiments. Although
for the most part, RNAi data agrees with our mutational
data, not every gene was supported by RNAi. We found
nine genes showing no lethal phenotype with RNAi and
three genes showing lethal phenotype of variable
penetrance (Table 1). Of the nine genes that show no
RNAi lethal phenotype, six (inx-12, coq-1, lim-7, tag-
146, let-381, and let-503) have additional knock-out
alleles that are lethal, suggesting RNAi did not reveal the
null phenotype of these genes. The additional information
Table 1 Coding DNA Sequence (CDS) identifications of let- genes
Gene Allele Allele mutation Molecular identity Support Confirmation status Human ortholog Associated human conditions References
lin-6/mcm-4 h92 C > * Mini chromosome maintenance RNAi Confirmed1 MCM4 Natural killer cell and glucocorticoid
deficiency with DNA repair defect
[39]
let-354/dhc-1 h79 Q > * Dynein heavy chain Both Confirmed1 DYNC1H1 Charcot-Marie-Tooth disease, Mental
retardation, Spinal muscular atrophy
[40-42]
let-502/rock h392 Q > * Rho associated kinase RNAi Confirmed1 ROCK1 [43]
let-363/tor h98 Splice variant Tor kinase Both Confirmed1 MTOR pancreatic neuroendocrine tumors [44,45]
h420a Q > * Confirmed3
h502a Splice variant Confirmed3
let-603/air-2 h289 W > * Aurora-related serine/threonine
kinase
Both Confirmed1 AURKA Susceptibility to colon cancer [46]
let-512/vps-34 h797 P > S phosphoinositide 3-kinase Confirmed1 PIK3C3 [47]
let-381/foxf h107 splice variant Forkhead transcription factor F K.O. Confirmed1 FOXF2 [48]
let-607/bZip h402 Q > * Leucine zipper transcription factor Both Confirmed1 CREB3L3 [49]
let-504/E01A2.4 h448 M > I NFkB activating protein Both Confirmed1 NKAP
let-152/ccb-1 h685 W > * Calcium channel subunit Confirmed2 CACNB2 Brugada syndrome 4
let-355/hel/
T05E8.3
h81 Y > * DEAD/H helicase RNAi Confirmed2 DHX33
let-362/rhel/
Y71G12B.8
h86 R > * DEAD/H RNA helicase RNAi Confirmed2 DDX27
let-366/aars-2 h112 Q > * Alanine tRNA synthetase RNAi Confirmed2 AARS Charcot-Marie-Tooth disease [50]
let-368/inx-12 h121 W > * Innexin gap junction K.O. Confirmed2
let-370/coq-1 h128 G > E hexaprenyl pyrophosphate
synthetase
K.O. Confirmed2 PDSS1 Coenzyme Q10 deficiency, Parkinson’s
disease
[51]
let-389/nars-1 h680 G > E Asparagine tRNA synthetase Both Confirmed2 NARS
let-396/fars-1 h217 Q > * Phenylalanine tRNA synthetase RNAi Confirmed2 FARSA
let-522/hlh-2 h735 W > * Helix loop helix transcription factor Both Confirmed2 TCF3 Acute lymphoblastic leukemia
let-529/asd-2 h238 Q > * KH domain containing RNA
binding protein
RNAi Confirmed2 QKI Mental retardation
let-575/ptr-2 h345 W > * Sterol sensing domain protein RNAi Confirmed2 PTCHD1 Autism spectrum disorders [52-54]
let-585/inx-13 h784 W > * Innexin gap junction RNAi Confirmed2
let-595/imb-1 h353 R > * Importin RNAi Confirmed2 KPNB1
let-598/F27C1.6 h213 Q > * U3 small nucleolar
ribonucleoprotein
RNAi Confirmed2 UTP14C
let-599/nath-10 h290 L > F N-acetyl transferase Both Confirmed2 NAT10
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Table 1 Coding DNA Sequence (CDS) identifications of let- genes (Continued)
let-608/ncbp-1 h706 Q > * Nuclear cap binding protein RNAi Confirmed2 NCBP1
let-611/C48E7.2 h756 Q > * RNA polymerase III subunit RNAi Confirmed2 POLR3C
let-612/apm-1 h466 splice variant Adaptin subunit RNAi Confirmed2 AP1M1
let-365/sep-1 h108 W > * Separase Both Confirmed2 ESPL1 Breast cancer oncogene
let-364/mat-1 h104 S > F Anaphase promoting complex
subunit
RNAi Confirmed2 CDC27
let-101/npp-6 h242 W > * Nuclear pore complex protein Both Confirmed2 NUP160
let-106/hcp-6 h787 C > Y Condensin subunit Both Confirmed2 NCAPD3
let-379/tag-345 h127 W > * Nucleolar protein complex
member
RNAi Confirmed2 WDR12
let-503/R12E2.2 h313 Q > * Protein of unknown function K.O. Confirmed2 SUCO
let-517/spg-7 h264 G > E Metalloprotease Both Confirmed2 AFG3L2 Spastic ataxia, Spinocerebellar ataxia
let-597/hcp-4 h349 E > * Holocentromeric protein RNAi Confirmed2 CENPC
let-630/
Y110A7A.19
h355b R > * Pentatricopeptide repeat
containing protein
RNAi Confirmed2 PTCD3
h782b W > * Confirmed2
let-646/pat-10 h233 G > E Troponin C RNAi Confirmed2 TNNC1 Cardiomyopathy
let-526 h799c Q > * SWI/SNF complex subunit Both Confirmed3 ARID1A Mental retardation
h405c W > * Confirmed3
let-129/zfh-2 h379 Q > * zinc finger homeobox protein Both Prediction ZFHX3, ZFHX4 Susceptibility to prostate cancer,
Ptosis
let-147/rnp-6 h463 G > E RNA splicing factor RNAi
range
Prediction PUF60 Verheij syndrome
let-373/unc-73 h234 Del Guanine nucleotide exchange factor Both Prediction TRIO
let-377/lim-7 h110 W > * LIM homeodomain protein K.O. Prediction ISL2
let-378/dnj-21 h124 G > E DnaJ domain containing protein RNAi Prediction DNAJC15
let-380/knl-2 h80 W > * Centromeric protein Both Prediction
let-382/nuo-2 h82 Q > * Mitochondria complex I subunit Both Prediction NDUFS3 Leigh syndrome, Mitochondrial
complex I deficiency
let-383/T21G5.6 h115 W > * Protein of unknown function Prediction
let-384/C06A5.1 h84 Q > * Integrator subunit RNAi Prediction INTS1
let-385/teg-4 h85 splice variant splicing factor RNAi Prediction SF3B3
let-386/dbr-1 h117 G > E RNA lariat-debranching enzyme RNAi
range
Prediction DBR1
let-391/tag-146 h91 Q > * Uncharacterized zinc finger protein K.O. Prediction
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Table 1 Coding DNA Sequence (CDS) identifications of let- genes (Continued)
let-397/rpb-5 h228 Q > * RNA polymerase II subunit RNAi Prediction POLR2E
let-400/prpf-4 h269 D > G Pre-mRNA processing factor RNAi Prediction PRPF4B [55]
let-509/unc-73 h142 W > * Guanine nucleotide exchange
factor
Both Prediction TRIO
let-527/nhr-23 h207 R > Q Nuclear hormone receptor Both Prediction RORC
let-534/ahcy-1 h260 Q > * S-adenosylhomocysteine hydrolase Both Prediction AHCY Hypermethioninemia
let-581/unc-11 h725 A > V clathrin adaptor protein RNAi;
Range
Prediction PICALM Acute lymphoblastic leukemia, Acute
T-cell lymphoblastic leukemia
let-601/cuti-1 h281 Q > * Cuticle regulatory protein Both Prediction
let-602/T09B4.9 h283 W > * translocase RNAi Prediction TIMM44
let-604/mdt-18 h293 splice variant Mediator subunit RNAi Prediction MED18
let-605/cye-1 h312 W > * E-type cyclin Both Prediction CCNE1
let-614 h138 Tested against F27C1.3 but did
not confirm
let-376 h130 Tested against F55F8.3 but did
not confirm
let-375 h241 Tested against imb-1 but did not
confirm
let-387 h87 Tested against pnk-1 but did not
confirm
let-515 h730 Tested against rpl-13 but did not
confirm
let-501 h714 Tested against rpl-4 but did not
confirm
let-361 h97 no candidate
let-531 h733 no candidate
let-576 h816 no candidate
let-518 h316 no candidate
let-523 h751 no candidate
let-525 h874 no candidate
let-584 h743 no candidate
The asterisk (*) signify a stop codon. Support column describes whether the CDS are lethal when treated with RNAi or a knock-out (K.O.) allele, or both. RNAi Range signifies RNAi lethal phenotype show varying degree
of penetrance. Confirmation status notes: 1Confirmed by previous publication. 2Confirmed by sequencing 2nd allele. 3Confirmed by complementation testing. Annotation of human orthologs and associated human
conditions are from the literature and public databases such as WormBase and OMIM. The genes are sorted first by confirmation status and then by genomic coordinates.
alet-103 (h420) and let-631 (h502) have collapsed into let-363.
blet-596 (h782) and let-630 (h355) both confirmed by sequencing a second allele and failed to complement each other. Thus, these two are collapsed into let-630.
clet-104 (h799) and let-519 (h405) have collapsed into let-526.
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our collection.
Essential genes in sDp2 function in cell cycle and
cytokinesis, transcriptional regulation, and RNA processing
To identify the processes that are essential, we investigated
the function of our high confidence gene set along with
their orthologs in D. melanogaster (fly), S. cerevisiae (yeast),
and H. sapiens (humans). Essential genes are often con-
served due to their important biological roles. Fifty-four
of our identified essential genes have readily identifiable
orthologs in humans [57] (Table 1). We further catego-
rized each gene into at least one of eight functional
groups based on their GO annotations (Figure 1). To
have a better picture of the roles of different essential
genes, multi-functional genes were categorized into more
than one functional group. The cell cycle & cytokinesis,
transcriptional regulation, transport, RNA processing, and
transcription categories contained more genes than did
the groups representing translation, signal transduction,
and the other groups that includes metabolic and struc-
tural processes.
Of these eight functional groups, we found three groups
that were significantly enriched in the sDp2 region when
compared to the non-essential genes in sDp2: cell cycle &
cytokinesis (p = 3.61e−9, χ2 test), regulation of transcription
(p = 6.21e−8, χ2 test), and RNA processing (p = 6.35e−12, χ2
test). Our analysis indicates that members of these pro-
cesses are enriched in essential genes. We have previously
shown that components of the spindle assembly check-
point are essential for survival [58]. Here we showed that
genes in the sDp2 region function in various phases of the
cell cycle. For instance, let-380 (knl-2) is critical for load-
ing hcp-3 (CENP-A) to chromatin and forming the kineto-
chore [59]. let-603 (air-2), let-597 (hcp-4), and let-106
(hcp-6) remove cohesions for proper resolution of cen-
tromeric connections and segregation of homologous
chromosomes during meiosis [60-62]. let-365 (sep-1) is es-
sential for chromatid separation and proper anaphase. In
addition, let-364 (mat-1), a member of the anaphase pro-
moting complex (APC), is crucial for the transition fromFigure 1 Functional categorization of essential genes identified in thi
The X-axis represents the number of genes in each category. Random sam
from either all sDp2 genes or the set of all essential genes identified by RNmetaphase to anaphase [63]. lin-6 (mcm-4) is required for
DNA replication and activates a checkpoint when entering
into M phase [39]. let-599 (nath-10) and let-354 (dhc-1)
are crucial for cytokinesis during cell division [64,65]. let-
385 (teg-4) is a component of splicing complex A that
functions in the meiosis entry decision [66,67]. Our data
indicate that disrupting any phase of the cell cycle process
can lead to lethality.
Are functions of the essential genes identified in this
study representative of all essential genes? Random
sampling simulation from 3500 essential genes indi-
cated by RNAi shows a very different GO term distribu-
tion (Figure 1). In the larger set samples, we observed
that cell cycle and cytokinesis (p = 1.02e−22, χ2 test), re-
gulation of transcription (p = 2.48e−20, χ2 test), and RNA
processing (p = 5.43e−10, χ2 test) are under-represented
compared to our sequenced set. Although we acknow-
ledge that comparing lethal mutants to RNAi phenocopies
is not fully equivalent, at the present time there is not a
large enough mutant essential gene collection to do this
comparison. It is intriquing nevertheless to raise the ques-
tion of regional differences in essential gene functions and
we look forward to having a more complete dataset that
can be used to address this issue.
Essential gene transcripts are supplied maternally
From the set of 59 essential genes, 34 of them arrest devel-
opment as embryos or early larvae, indicating that they
are important early in development. To test this hypoth-
esis, we analyzed the temporal expression of these genes
using RNA-seq divided into 23 separate 30-minute embry-
onic stages, 4 larval stages, pre-gravid young adult stage,
and the young adult stage. The normalized RNA-seq data
was obtained from the modENCODE project [68,69].
Seven distinct patterns were seen from the heatmap
(Figure 2). Five genes (colored red) express highly during
mid-embryonic stage (300 min – 600 min), six genes (col-
ored blue) express highly during late-embryonic stage
(600 min – hatch), and seven genes (colored green) ex-
press highly in both mid-embryonic and late-embryonic
stages. Eighteen genes (colored purple) show elevateds study using GO terms. The Y-axis indicates the GO term categories.
pling of 1000 iterations was done by selecting equal number of genes
Ai. Error bars represent standard error.
Figure 2 This figure represents the normalized transcript level (read number per coding length per million reads) for each gene across
the developmental stages including 23 embryo stages separated by 30 minute interval, four larval stages (L1-L4), pre-gravid young
adult, and gravid young adult. For comparing germline expression, we’ve included the transcript level from JK1107 carrying a mutation in
glp-1, which is essential for mitotic germ cell proliferation [71]. The heatmap represents normalized transcript level from high (yellow) to low
(blue). Seven distinct clusters that are based on their expression pattern are shown by colored branches. Purple: early-embryonic; Brown:
early- and mid-embryonic; Red: mid-embryonic; Blue: late-embryonic; Green: mid- and late-embryonic; Orange: gastrulation; Black: larval.
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300 min). Most of these genes, however, had a dramatic
drop in expression level at 150 min, which is when gas-
trulation occurs [70]. Observing that many of these genes
also show strong expression in young adults but not in lar-
val stages suggests that these messages are highly tran-
scribed in the germline and are likely maternally derived
in the embryo. On the other hand, nine genes (colored
brown) show some early embryonic expression but have
their strongest expression during mid-embryonic stages. A
group of four genes (colored orange) show specific expres-
sion during gastrulation. Lastly, eight genes (colored black)
have elevated expression during specific larval stages.From the RNAseq data, we observed 18 genes with ex-
pression patterns that indicated maternal contribution
during early embryogenesis. This ratio is not significantly
different from the set of all essential genes. However, when
compared with the set of non-essential genes, our essential
gene list is significantly enriched for genes with strong ma-
ternal contribution (1.24e−5, χ2 test). These data indicate
that many essential genes important for early embryonic
development have maternal contribution.
Conclusions
The function of essential genes is poorly understood.
Having a combination of genetic strains for which the
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source for their study. However, even in the model system
C. elegans, only about 25% of the essential genes have a
knockout alleles. RNAi has also been used to identify essen-
tial genes [72,73]. Despite the success of these studies, only
a small subset (~800 genes) have been profiled phenotypic-
ally [72]. We have a large collection of mutant strains, but
only now has it been technically feasible to easily identify
their corresponding coding regions. Our library currently
consists of 1350 lethal mutations maintained by balancers
in chromosomes I, III, IV, and V, of which chromosome I
is the closest to saturation [19]. Recent whole genome
screening experiments using the CRISPR/Cas9 system have
opened up the possibility of identifying essential genes
using this targeted approach. However, targeted approaches
directed towards identifying essential genes in an intact
multicellular organism are still limited in terms of recovery
and maintenance of lethal mutations and impractical for
large scale screens. The relative ease of capturing and
maintaining lethal mutations makes balancer systems the
method of choice for essential gene studies. However, using
random mutagenesis is not possible to achieve 100% sa-
turation (finding all essential genes). Small targets have a
smaller chance of being mutated and are likely missed in
mutagenesis experiments. Also, finding new essential genes
in subsequent screenings becomes more and more difficult
because the screens follow (approximately) a Poisson distri-
bution giving diminishing returns. Thus, a combination of
targeted and forward mutational approaches is best.
We previously developed a pipeline and applied it to
the identification of let-504 [30]. In the analysis pre-
sented here, we applied the pipeline to further analyze
76 essential genes on Chromosome I and produced high
confidence identification for 64 genes. Some of the con-
firmed candidates were found outside the mapped re-
gion suggesting that the boundaries of the genetically
identified zones can be further refined. We have shown
that our approach is much more efficient and cost-
effective than the traditional method. Assessments from
this study will help us improve our identification pipe-
line and give us the confidence to apply this technique
to the rest of our collection of essential genes.
Our results here provide additional alleles to known
genes as well as provide new alleles. The added alleles
will be valuable for establishing allelic series that may
exhibit different phenotypes. For instance let-147/rnp-6
has 4 alleles each showing a different arrest stage [19],
suggesting different protein domains are being disrupted.
More importantly, our results provided 13 new alleles in
essential genes where no alleles existed. The genetic re-
sources provided with our method will be beneficial to
the field of essential gene research.
We have demonstrated here that Let mutants can be
used, not only individually to study the gene’s function,but analyzed as a group to better understand the functions
a living multi-cellular animal needs for survival. Under-
standing the function of individual essential genes has ap-
plications for medicine. Essential genes in bacteria have
been exploited to develop new antimicrobials [5]. An un-
derstanding of essential genes can be exploited for new
medical uses. For example, the human ortholog of let-400/
prpf-4, has been found to induce G1/S arrest and may
function as a cancer suppressor [55]. Therefore, a resource
such as described here for identifying and studying essen-
tial genes in model organisms has direct benefit.
We have shown that essential genes in the left half of
chromosome I in C. elegans function in cell cycle control,
transcriptional regulation, and RNA processing. Previous
reports studying other genomic regions have shown differ-
ent gene classes such as those regulated by the GATA tran-
scription factor [74] and the sex-regulated genes [75] are
non-randomly distributed in the genome. Thus, we believe
the organization of these genes within the genome is also
non-random. With our method, it is now possible to gener-
ate genetic resources to capture the majority of the essen-
tial genes. The study of which will provide us with a global
picture of the minimum set of genes and pathways that is
needed for the survival of a multi-cellular organism, and
their organization in the genome. An increased under-
standing of the nature of essential genes is relevant not only
to our knowledge of the biological survival of the organism
but also has the potential for better medical procedures.
Methods
Strains
The strains used in this study are listed in Table 1. We
have listed all the other available alleles for each let-
gene in Additional file 2. The strains were grown and
maintained on nematode growth medium streaked with
E. coli OP50 [76]. The strains used in this study were
generated by mutagenizing KR235 [dpy-5 (e61), +, unc-
13 (e450)/dpy-5(e61), unc-15(e73), +; sDp2] with 12 mM
EMS [35]. Briefly, the treated gravid wildtypes were indi-
vidually plated on 5 cm plates and wildtype gravid F1s
were also individually plated 5 days later. Their progeny
(F2s) were screened for the absence of Dpy-5 Unc-13 in-
dividuals (Additional file 1). A single Unc-13 animal was
transferred to confirm the existence of a lethal mutation.
A balanced lethal would exhibit Unc-13 and develop-
mentally arrested Dpy-5 Unc-13 [35]. All the strains
were maintained at 20°C and by selecting Unc animals.
Each strain was grown from one hermaphrodite and ex-
panded to 20 2-inch plates. The worms were collected
by rinsing the plates with M9 (6 g Na2HPO4, 3 g
KH2PO4, 5 g NaCl, 0.2 g MgSO4 in 1 L of H20). The
worms were washed with 12 ml of M9 three times and
incubated at room temperature for 2 hours. The final
pellet was frozen in −80°C.
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Genomic DNA was extracted by phenol/chloroform as
described previously [30]. Briefly, the worm pellet was
lysed in 0.5% SDS and 100ug of Proteinase K in 50°C for
two hours. DNA was extracted with phenol/chloroform
three times and precipitated with 100% ethanol. 20 ug of
RNase A was added to the eluted sample to remove
RNA contaminants and this was followed by three more
rounds of phenol/chloroform extraction and ethanol
precipitation. 10 ug of purified genomic DNA was se-
quenced at the BC Cancer Agency Genome Sciences
Centre using Illumina PET HiSeq technology.
Mutation identification procedure
Sequencing reads were aligned to the WS200 C. elegans
genome using BWA [36] under default settings. Dupli-
cated reads were filtered with GATK [77]. Further realign-
ment around indels was also done with GATK. The BAM
files were analyzed for SNV and small indels using Varscan
[78]. The SNVs or indels returned by Varscan were filtered
by 1) mutations in the parental strain KR235 mutation,
2) variant ratio (90% > x > 40%), and 3) genomic location
(in coding sequences only). Allelic ratio was calculated as
the ratio of mutant allele:reference allele. The effect for
each CDS from the accumulate effect of the mutations in
the genome was analyzed using Coovar [79]. Mutational
landscape analysis was done using SNVs exhibiting G >A
or C > T transitions as described previously [30]. Each
genes in the sDp2 carrying a non-synonymous mutation
was considered and ranked according to the severity of
the mutation. Mapping information from [19] was used as
a guide to find the most likely mutation. The mutations
for each strain can be downloaded from http://lethal.mbb.
sfu.ca/jschu/essential_genes.
Sequencing of a second allele was done with Sanger
sequencing or WGS. PCR primers were designed using
Primer3 [80,81] spaced 250 bp apart with staggered
orientation. This allowed sufficient overlap so that each
position was covered at least twice. The Sanger reads
were aligned to the wildtype transcript sequence using
Clustal [82]. The alignments from each Sanger read were
merged and analyzed with Bioedit. A mutation was con-
firmed if it was supported by all the Sanger reads and
the sequencing traces show a clear double peak. A pre-
diction was also confirmed when WGS of a second allele
has a different mutation in the same gene.
Confirmation by complementation testing
Allelic combinations were established previously by com-
plementation testing as described in [19] with the following
exceptions. In a few cases, candidate SNVs were found for
mutations, which were previously described as mapping to
separate zones, in a single coding region. In these cases
complementation testing was done between mutationspredicted to be in the candidate coding region and con-
firmed that they did form a single complementation group
as shown in Additional file 3.
Strains carrying a lethal mutation were selected for com-
plementation testing with other lethal-carrying strains
based on the identification of candidate mutations in the
same gene. In order to determine allelism, let-x dpy-5 unc-
13/let-x dpy-5 unc-13; sDp2 hermaphrodites were mated
to wild-type males. F1 males (let-x dpy-5 unc-13/ + + +)
were crossed to hermaphrodites carrying a second lethal
(let-y dpy-5 unc-13/let-y dpy-5 unc-13; sDp2). The diag-
nostic phenotype indicating complementation in the
progeny of the cross was Dpy Unc males and fertile her-
maphrodites (let-x dpy-5 unc-13/let-y dpy-5 unc-13). A
minimum of ten wild-type males on one plate was con-
sidered sufficient to conclude that the absence of Dpy
Unc animals was not due to poor mating.
Gene ontology analysis
Orthologs were predicted by a set of programs consisting
of Inparanoid [83], OrthoMCL [84], and Ensembl-Compara
[85] with methods as previously described [57]. The protein
sets used were: C. elegans (WS230), S. cerevisiae (64-1-1),
D. melanogaster (r5.46), and H. sapiens (GRCh37.66). GO
annotation was done using Blast2GO [86]. GO profile com-
parison was done using all the genes under sDp2 and all
the essential genes as identified by RNAi collected from
WormBase WS230.
RNA-seq expression analysis
Normalized RNA-seq data were downloaded from the
modEncode website (www.modencode.org). The average
normalized read count for each CDS was calculated as
the total normalized read count of all coding base-pairs
divided by the length of CDS. The expression profile
clustering was done using agnes clustering in R.
Additional files
Additional file 1: This figure describes how lethal mutations are
balanced with sDp2 [35]. KR235 is mutagenized with 12 mM EMS.
The treated gravid wildtypes were individually plated on 5 cm plates and
wildtype gravid F1s were also individually plated 5 days later. Their
progeny (F2s) were screened for the absence of Dpy-5 Unc-13 individuals.
A single Unc-13 animal was transferred to confirm the existence of a
lethal mutation. A balanced lethal would exhibit Unc-13 and developmentally
arrested Dpy-5 Unc-13. The asterisk (*) denotes an EMS mutation. In the
F1 generation, the mutation could be on either homolog but not both.
Additional file 2: List of genes studied and their associated alleles.
The alleles used for WGS are listed in the 2nd column. The alleles used for
confirmation are noted by an asterisk (*).
Additional file 3: Comparison of genomes missing dpy-5 and/or
unc-13 markers. The average read depth per 10Kbp of coding element
is plotted along the length of chromosome I. The x-axis shows the
coordinate in 10 K units. The y-axis shows the number of reads.
The control genome show 33% more reads in the first 7 Mbp while the
genome with missing markers shows a flat distribution.
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http://www.biomedcentral.com/1471-2164/15/361Additional file 4: Complementation table for let-363 (h98), let-130
(h216), let-130 (h451), let-631 (h502), let-630 (h355), let-596 (h782),
let-526 (h185), let-104 (h799), and let-519 (h405). (−) indicates two
mutations fail to complement and (+) indicates two mutations
complement each other. N.D. indicates the particular combination was
not done.
Abbreviations
WGS: Whole genome sequencing; SNV: Single nucleotide variation;
EMS: Ethyl methanesulfonate; GO: Gene ontology.
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